Pulmonary Arterial Hypertension Treatment Market size and forecast, 2016-2026


Future Market Insights has announced the addition of the “ Pulmonary Arterial Hypertension Treatment Market: Global Industry Analysis and Opportunity Assessment 2016-2026”report to their offering.

According to World Health Organization (WHO), raised blood pressure is estimated to cause 7.5 million deaths around the world. Hypertension is a risk factor for coronary heart disease, ischemic and hemorrhagic stroke. In addition complications of hypertension includes peripheral vascular disease, heart failure, renal impairment, retinal hemorrhage and visual impairment.

Having family history of Pulmonary Arterial Hypertension, change in life style, unhealthy food, and physical inactivity causes hypertension.    

To treat pulmonary atrial hypertension following treatments are available

Medication

Surgeries 

Medications include blood vessel dilators (vasodilators), Endothelin receptor antagonists, phosphodiesterase III inhibitors, calcium channel blockers, anticoagulants, diuretics.

Atrial septostomy and Transplantation are the two surgery option for patients who suffering from severe pulmonary atrial hypertension. Transplantation is may be an option for younger people who are suffering from idiopathic pulmonary hypertension.

Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1218 

Pulmonary Arterial Hypertension Treatment Market: Drivers and Restraints

According to World Health Organization, Globally the prevalence rate of hypertension was 40% in adults who aged 25 and above in the year 2008. The prevalence rate is high in Africa region and Americas having less prevalence rate in hypertension. Change in the life style, family history of pulmonary atrial hypertension, unhealthy food, and physical inactivity are the risk factors for hypertension as well as drivers for this market. Raising the geriatric population around the world also driver for pulmonary atrial hypertension treatment market. Guidelines form government organizations such as World Health Organization (WHO), Center for Disease Control and Prevention plays a major role in the prevention of pulmonary atrial hypertension treatment.

Pulmonary Arterial Hypertension Treatment Market: Segmentation 

Pulmonary Arterial Hypertension Treatment Market is segmented into following types:

Based on Treatment

Medication

Blood Vessel Dilators (Vasodilators)

Endothelin Receptor Antagonists

Phosphodiesterase III Inhibitors

Calcium Channel Blockers

Anticoagulants

Diuretics

Based on End User

Hospital

Drug store

Hospital Pharmacies

Pulmonary Arterial Hypertension Treatment Market: Overview

With good awareness about healthcare among people and guidance from international organizations about the Pulmonary Arterial Hypertension Treatment, the market is expected to have a healthy growth in the forecast period (2016-2026)  

Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1218 

Pulmonary Arterial Hypertension TreatmentMarket: Region- wise Outlook 

Depending on geographic regions, the global Pulmonary Arterial Hypertension Treatment market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.    

Pulmonary Arterial Hypertension Treatment is high in North America because it is highly developed region, having good healthcare setup and people are having good awareness about health care. Asia Pacific is expected to grow at a remarkable CAGR. Europe also having good growth in this market.  

Pulmonary Arterial Hypertension TreatmentMarket: Key Players

Some of the key players in this market are

Pfizer inc.

Bristol myers co

Novartis AG.

GlaxoSmithKline Pharmaceuticals Limited

Baxter

Dr. Reddy’s Laboratories Ltd.

Browse Full Report@ http://www.futuremarketinsights.com/reports/pulmonary-arterial-hypertension-treatment-market 

Products or Services

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature

Contact Information

Future Market Insights

616 Corporate Way, Suite 2-9018,, Valley Cottage, NY 10989,, United States,
New York
10989
United States
Phone : 3479183531
View website

Published in

Business

Published on

Nov 22, 2016